Ginsenoside Rb1 inhibits chronic stress-induced colorectal cancer via regulating glycolysis and β2-AR/CREB1 signaling pathway
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Wang Yao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Ginsenosides, Colorectal Neoplasms, Glycolysis, Receptors, Adrenergic, beta-2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To investigate the mechanism of ginsenoside Rb1 (G-Rb1) against colorectal cancer under chronic stress.
Methods
A chronic restraint stress (CRS) model and a colorectal cancer (CRC) subcutaneous xenograft model were established. Western blot analysis quantified β2-adrenergic receptor (β2-AR), cAMP response element-binding protein 1 (CREB1), and p-CREB1 expression. Additionally, glycolytic enzymes GLUT1, HK2, and PFKP were analyzed via Western blot and RT-qPCR, with glucose uptake, lactate, ATP, and stress hormone levels assessed by flow cytometry, kits, and ELISA. Key findings Compared to the control group, the stress group exhibited increased tumor volume and mass, along with elevated expression of β2-AR, p-CREB1, and upregulated expression levels of GLUT1, HK2, and PFKP. Additionally, glucose, lactate, and epinephrine levels were higher in the stress group. In comparison to the stress group, G-Rb1 treatment demonstrated reduced tumor volume and mass, decreased p-CREB1 expression, as well as downregulated protein and mRNA levels of GLUT1, HK2, and PFKP. Glucose, lactate, and epinephrine levels also showed a reduction in the G-Rb1-treated groups.
Conclusions
G-Rb1 suppresses the growth of colorectal cancer under chronic stress, potentially through downregulation of the β2-AR/CREB1 signaling pathway, thereby reducing glycolytic activity in colorectal cancer under chronic stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
ORCID-Profile: Yun-Feng Guan, Yan Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yao, W., Hua, D. M., Wang, W. K., Zhang, Z. Z., Guan, Y. F., & Wang, Y. (2025). Ginsenoside Rb1 inhibits chronic stress-induced colorectal cancer via regulating glycolysis and β2-AR/CREB1 signaling pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf031
Vancouver
Yao W, Hua DM, Wang WK, Zhang ZZ, Guan YF, Wang Y. Ginsenoside Rb1 inhibits chronic stress-induced colorectal cancer via regulating glycolysis and β2-AR/CREB1 signaling pathway. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf031
BibTeX
@article{Yao2025,
author = {Yao, Wang and Hua, Dong-Ming and Wang, Wen-Kai and Zhang, Zhao-Zhou and Guan, Yun-Feng and Wang, Yan},
title = {Ginsenoside Rb1 inhibits chronic stress-induced colorectal cancer via regulating glycolysis and β2-AR/CREB1 signaling pathway},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf031}
}
EUVIMED